IMFG Group Hosts International Conference in Taiwan, Focusing on the Future of Cryptocurrency and AI’s Impact on Financial Markets

02-27

Dongying Celebrates 2025 Lantern Festival With Wonderful Performances

02-27

China y Laos construyen conjuntamente un Centro de Cooperación en Innovación de Inteligencia Artificial

El 23 de febrero de 2025, China y Laos celebraron una ceremonia de firma en la capital de Laos, Vientián, para la creación conjunta del Centro de Cooperación en Innovación de Inteligencia Artificial China-Laos.

02-27

NETSCOUT Applauded by Frost & Sullivan for Enabling Real-Time Visibility into Network Traffic with Competitive Strategies

NETSCOUT\'s solutions provide actionable intelligence through powerful deep packet inspection,behavioral analytics,and AI-driven insights

02-26

ASUS to Present Transformative AI Infrastructure Solutions at NVIDIA GTC 2025 as Diamond Sponsor

ASUS will unveil its latest advancements in AI infrastructure from AI servers to edge AI solutions for diverse enterprise needs

02-26

How 51Talk is Redefining Online Education Through AI--from the Boardroom to the Classroom

SINGAPORE,Feb. 25,2025--51Talk,an online English language education platform,has announced plans to launch a comprehensive,AI-powered systems upgrade across its business operations within the coming m

02-26

WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development

SHANGHAI,Feb. 25,2025-- WuXi XDC Cayman Inc. ("WuXi XDC",or the "Company",stock code: 2268.HK),a leading global CRDMO (Contract Research,Development,and Manufacturing Organization)

02-26

Plume's New 5G.11 Offload Helps Communications Service Providers Boost Cellular Coverage and Reduce Costs

PALO ALTO,Calif.,Feb. 25,2025-- Plume,the pioneer in cloud-based platform services focused on enriching subscriber experiences for Communications Service Providers (CSPs),today announced the expansio

02-26

e& delivers record revenue and net profit in FY 2024 growing consolidated revenue 10.1% to AED 59.2 billion

Net profit reached AED 10.8 billion,growing 4.3 per cent year-over-year Full year dividend per share of 83 fils

02-26

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

MELBOURNE,Australia,Feb. 26,2025--Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted

02-26